Venture Life Group (LON:VLG) Insider Purchases £49,839.44 in Stock

Venture Life Group plc (LON:VLG) insider Mark Adams acquired 88,999 shares of the firm’s stock in a transaction on Friday, October 3rd. The stock was bought at an average price of GBX 56 per share, with a total value of £49,839.44.

Venture Life Group Stock Performance

LON VLG opened at GBX 55 on Monday. Venture Life Group plc has a 1 year low of GBX 32 and a 1 year high of GBX 66. The company has a fifty day moving average of GBX 58.46 and a two-hundred day moving average of GBX 51.93. The company has a market capitalization of £70.43 million, a PE ratio of -7,236.84, a P/E/G ratio of 5.67 and a beta of 0.30. The company has a debt-to-equity ratio of 28.45, a current ratio of 2.22 and a quick ratio of 1.48.

Venture Life Group (LON:VLG) last announced its earnings results on Tuesday, September 30th. The company reported GBX 0.83 earnings per share (EPS) for the quarter. Venture Life Group had a net margin of 1.44% and a return on equity of 0.99%. As a group, analysts expect that Venture Life Group plc will post 6.1391542 earnings per share for the current year.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.

With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.